Ken Griffin's position in Cullinan Therapeutics is currently worth $30.1 Million. That's 0.03% of their equity portfolio (639th largest holding). The investor owns 2.57% of the outstanding Cullinan Therapeutics stock. The first Cullinan Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares eight more times and sold shares on three occasions. The stake costed the investor $15.3 Million, netting the investor a gain of 97% so far.